Identification of PrP sequences essential for the interaction between the PrP polymers and Aβ peptide in a yeast-based assay

References

• Selkoe DJ, Schenk D. Alzheimer’s disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003; 43:545 - 84; http://dx.doi.org/10.1146/annurev.pharmtox.43.100901.140248; PMID: 12415125
   PubMed Web of Science ®Google Scholar
• Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol 2007; 8:101 - 12; http://dx.doi.org/10.1038/nrm2101; PMID: 17245412
   PubMed Web of Science ®Google Scholar
• Klyubin I, Walsh DM, Lemere CA, Cullen WK, Shankar GM, Betts V, Spooner ET, Jiang L, Anwyl R, Selkoe DJ, et al. Amyloid beta protein immunotherapy neutralizes Abeta oligomers that disrupt synaptic plasticity in vivo.. Nat Med 2005; 11:556 - 61; http://dx.doi.org/10.1038/nm1234; PMID: 15834427
   PubMed Web of Science ®Google Scholar
• Lambert MP, Barlow AK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B, Viola KL, et al. Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 1998; 95:6448 - 53; http://dx.doi.org/10.1073/pnas.95.11.6448; PMID: 9600986
   PubMed Web of Science ®Google Scholar
• Renner M, Lacor PN, Velasco PT, Xu J, Contractor A, Klein WL, Triller A. Deleterious effects of amyloid beta oligomers acting as an extracellular scaffold for mGluR5. Neuron 2010; 66:739 - 54; http://dx.doi.org/10.1016/j.neuron.2010.04.029; PMID: 20547131
   PubMed Web of Science ®Google Scholar
• Wang Y, Meriin AB, Zaarur N, Romanova NV, Chernoff YO, Costello CE, Sherman MY. Abnormal proteins can form aggresome in yeast: aggresome-targeting signals and components of the machinery. FASEB J 2009; 23:451 - 63; http://dx.doi.org/10.1096/fj.08-117614; PMID: 18854435
   PubMed Web of Science ®Google Scholar
• Xie L, Helmerhorst E, Taddei K, Plewright B, Van Bronswijk W, Martins R. Alzheimer’s beta-amyloid peptides compete for insulin binding to the insulin receptor. J Neurosci 2002; 22:RC221; PMID: 12006603
   PubMed Web of Science ®Google Scholar
• Laurén J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature 2009; 457:1128 - 32; http://dx.doi.org/10.1038/nature07761; PMID: 19242475
   PubMed Web of Science ®Google Scholar
• Kudo W, Petersen RB, Lee HG. Cellular prion protein and Alzheimer disease: link to oligomeric amyloid-β and neuronal cell death. Prion 2013; 7:114 - 6; http://dx.doi.org/10.4161/pri.22848; PMID: 23154635
   PubMed Web of Science ®Google Scholar
• Prusiner SB. Prions. Proc Natl Acad Sci U S A 1998; 95:13363 - 83; http://dx.doi.org/10.1073/pnas.95.23.13363; PMID: 9811807
   PubMed Web of Science ®Google Scholar
• Resenberger UK, Harmeier A, Woerner AC, Goodman JL, Müller V, Krishnan R, Vabulas RM, Kretzschmar HA, Lindquist S, Hartl FU, et al. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication. EMBO J 2011; 30:2057 - 70; http://dx.doi.org/10.1038/emboj.2011.86; PMID: 21441896
   PubMed Web of Science ®Google Scholar
• Chen S, Yadav SP, Surewicz WK. Interaction between human prion protein and amyloid-beta (Abeta) oligomers: role OF N-terminal residues. J Biol Chem 2010; 285:26377 - 83; http://dx.doi.org/10.1074/jbc.M110.145516; PMID: 20576610
   PubMed Web of Science ®Google Scholar
• Fluharty BR, Biasini E, Stravalaci M, Sclip A, Diomede L, Balducci C, La Vitola P, Messa M, Colombo L, Forloni G, et al. An N-terminal fragment of the prion protein binds to amyloid-β oligomers and inhibits their neurotoxicity in vivo. J Biol Chem 2013; 288:7857 - 66; http://dx.doi.org/10.1074/jbc.M112.423954; PMID: 23362282
   PubMed Web of Science ®Google Scholar
• Morales R, Estrada LD, Diaz-Espinoza R, Morales-Scheihing D, Jara MC, Castilla J, Soto C. Molecular cross talk between misfolded proteins in animal models of Alzheimer’s and prion diseases. J Neurosci 2010; 30:4528 - 35; http://dx.doi.org/10.1523/JNEUROSCI.5924-09.2010; PMID: 20357103
   PubMed Web of Science ®Google Scholar
• Coughlan CM, Brodsky JL. Use of yeast as a model system to investigate protein conformational diseases. Mol Biotechnol 2005; 30:171 - 80; http://dx.doi.org/10.1385/MB:30:2:171; PMID: 15920289
   PubMed Web of Science ®Google Scholar
• Mason RP, Giorgini F. Modeling Huntington disease in yeast: perspectives and future directions. Prion 2011; 5:269 - 76; PMID: 22052350
   PubMed Web of Science ®Google Scholar
• Braun RJ, Büttner S, Ring J, Kroemer G, Madeo F. Nervous yeast: modeling neurotoxic cell death. Trends Biochem Sci 2010; 35:135 - 44; http://dx.doi.org/10.1016/j.tibs.2009.10.005; PMID: 19926288
   PubMed Web of Science ®Google Scholar
• Gong H, Romanova NV, Allen KD, Chandramowlishwaran P, Gokhale K, Newnam GP, Mieczkowski P, Sherman MY, Chernoff YO. Polyglutamine toxicity is controlled by prion composition and gene dosage in yeast. PLoS Genet 2012; 8:e1002634; http://dx.doi.org/10.1371/journal.pgen.1002634; PMID: 22536159
   PubMedGoogle Scholar
• Ma J, Lindquist S. De novo generation of a PrPSc-like conformation in living cells. Nat Cell Biol 1999; 1:358 - 61; http://dx.doi.org/10.1038/14053; PMID: 10559963
   PubMed Web of Science ®Google Scholar
• Mallik S, Yang W, Norstrom EM, Mastrianni JA. Live cell fluorescence resonance energy transfer predicts an altered molecular association of heterologous PrPSc with PrPC. J Biol Chem 2010; 285:8967 - 75; http://dx.doi.org/10.1074/jbc.M109.058107; PMID: 20086009
   PubMed Web of Science ®Google Scholar
• Meriin AB, Zhang X, He X, Newnam GP, Chernoff YO, Sherman MY. Huntington toxicity in yeast model depends on polyglutamine aggregation mediated by a prion-like protein Rnq1. J Cell Biol 2002; 157:997 - 1004; http://dx.doi.org/10.1083/jcb.200112104; PMID: 12058016
   PubMed Web of Science ®Google Scholar
• Winderickx J, Delay C, De Vos A, Klinger H, Pellens K, Vanhelmont T, Van Leuven F, Zabrocki P. Protein folding diseases and neurodegeneration: lessons learned from yeast. Biochim Biophys Acta 2008; 1783:1381 - 95; http://dx.doi.org/10.1016/j.bbamcr.2008.01.020; PMID: 18298958
   PubMed Web of Science ®Google Scholar
• Kryndushkin DS, Alexandrov IM, Ter-Avanesyan MD, Kushnirov VV. Yeast [PSI+] prion aggregates are formed by small Sup35 polymers fragmented by Hsp104. J Biol Chem 2003; 278:49636 - 43; http://dx.doi.org/10.1074/jbc.M307996200; PMID: 14507919
   PubMed Web of Science ®Google Scholar
• Urakov VN, Vishnevskaya AB, Alexandrov IM, Kushnirov VV, Smirnov VN, Ter-Avanesyan MD. Interdependence of amyloid formation in yeast: implications for polyglutamine disorders and biological functions. Prion 2010; 4:45 - 52; http://dx.doi.org/10.4161/pri.4.1.11074; PMID: 20118659
   PubMed Web of Science ®Google Scholar
• Ishikawa-Ankerhold HC, Ankerhold R, Drummen GP. Advanced fluorescence microscopy techniques--FRAP, FLIP, FLAP, FRET and FLIM. Molecules 2012; 17:4047 - 132; http://dx.doi.org/10.3390/molecules17044047; PMID: 22469598
   PubMed Web of Science ®Google Scholar
• Apodaca J, Kim I, Rao H. Cellular tolerance of prion protein PrP in yeast involves proteolysis and the unfolded protein response. Biochem Biophys Res Commun 2006; 347:319 - 26; http://dx.doi.org/10.1016/j.bbrc.2006.06.078; PMID: 16808901
   PubMed Web of Science ®Google Scholar
• Caine J, Sankovich S, Antony H, Waddington L, Macreadie P, Varghese J, Macreadie I. Alzheimer’s Abeta fused to green fluorescent protein induces growth stress and a heat shock response. FEMS Yeast Res 2007; 7:1230 - 6; http://dx.doi.org/10.1111/j.1567-1364.2007.00285.x; PMID: 17662055
   PubMed Web of Science ®Google Scholar
• Yang W, Yang H, Tien P. In vitro self-propagation of recombinant PrPSc-like conformation generated in the yeast cytoplasm. FEBS Lett 2006; 580:4231 - 5; http://dx.doi.org/10.1016/j.febslet.2006.06.074; PMID: 16831424
   PubMed Web of Science ®Google Scholar
• Mitkevich OV, Kochneva-Pervukhova NV, Surina ER, Benevolensky SV, Kushnirov VV, Ter-Avanesyan MD. DNA aptamers detecting generic amyloid epitopes. Prion 2012; 6:400 - 6; http://dx.doi.org/10.4161/pri.20678; PMID: 22874671
   PubMed Web of Science ®Google Scholar
• Derkatch IL, Uptain SM, Outeiro TF, Krishnan R, Lindquist SL, Liebman SW. Effects of Q/N-rich, polyQ, and non-polyQ amyloids on the de novo formation of the [PSI+] prion in yeast and aggregation of Sup35 in vitro.. Proc Natl Acad Sci U S A 2004; 101:12934 - 9; http://dx.doi.org/10.1073/pnas.0404968101; PMID: 15326312
   PubMed Web of Science ®Google Scholar
• Lau AL, Yam AY, Michelitsch MM, Wang X, Gao C, Goodson RJ, Shimizu R, Timoteo G, Hall J, Medina-Selby A, et al. Characterization of prion protein (PrP)-derived peptides that discriminate full-length PrPSc from PrPC. Proc Natl Acad Sci U S A 2007; 104:11551 - 6; http://dx.doi.org/10.1073/pnas.0704260104; PMID: 17601775
   PubMed Web of Science ®Google Scholar
• Kaiser C, Michaelis S, Mitchell A. Methods in yeast genetics: a Cold Spring Harbor Laboratory course manual.: Plainview, N.Y.: Cold Spring Harbor Laboratory Press, 1994.
   Google Scholar
• Sherman F, Fink GR, Hancks JB. Methods in yeast genetics. New York: Cold Spring Harbor Laboratory Press, 1986.
   Google Scholar
• Hanahan D. Techniques for transformation of E. coli. DNA cloning 1985; Glocer, P.M. (ed.), IRL Press, Oxford,1:109-35.
   Google Scholar
• Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual.: Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press, 1989.
   Google Scholar
• Narwa R, Harris DA. Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors. Biochemistry 1999; 38:8770 - 7; http://dx.doi.org/10.1021/bi990736c; PMID: 10393552
   PubMed Web of Science ®Google Scholar
• Sikorski RS, Hieter P. A system of shuttle vectors and yeast host strains designed for efficient manipulation of DNA in Saccharomyces cerevisiae. Genetics 1989; 122:19 - 27; PMID: 2659436
   PubMed Web of Science ®Google Scholar
• Rubel’ AA, Saĭfitdinova AF, Lada AG, Nizhnikov AA, Inge-Vechtomov SG, Galkin AP. [Yeast chaperone Hspl04 regulates gene expression on the posttranscriptional level]. Mol Biol (Mosk) 2008; 42:123 - 30; PMID: 18389629
   PubMed Web of Science ®Google Scholar
• Chernoff YO, Uptain SM, Lindquist SL. Analysis of prion factors in yeast. Methods Enzymol 2002; 351:499 - 538; http://dx.doi.org/10.1016/S0076-6879(02)51867-X; PMID: 12073366
   PubMed Web of Science ®Google Scholar
• Bagriantsev SN, Kushnirov VV, Liebman SW. Analysis of amyloid aggregates using agarose gel electrophoresis. Methods Enzymol 2006; 412:33 - 48; http://dx.doi.org/10.1016/S0076-6879(06)12003-0; PMID: 17046650
   PubMed Web of Science ®Google Scholar
• Verstrepen KJ, Van Laere SD, Vercammen J, Derdelinckx G, Dufour JP, Pretorius IS, Winderickx J, Thevelein JM, Delvaux FR. The Saccharomyces cerevisiae alcohol acetyl transferase Atf1p is localized in lipid particles. Yeast 2004; 21:367 - 77; http://dx.doi.org/10.1002/yea.1100; PMID: 15042596
   PubMed Web of Science ®Google Scholar
• Thakur MS, Prapulla SG, Karanth NG. Microscopic Observation of Sudan Black B Staining to monitor Lipid production by Microbes. J Chem Technol Biotechnol 1988; 42:129 - 34; http://dx.doi.org/10.1002/jctb.280420206
   Web of Science ®Google Scholar